WebOct 15, 2024 · Chinook to host investor conference call and webcast on November 4, 2024 to review abstracts and provide updates on the company’s pipeline; SEATTLE, ... Chinook’s lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. BION-1301, an anti-APRIL ... WebApr 15, 2024 · Chinook’s lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a phase 1b trial for IgA nephropathy. In addition, Chinook is advancing CHK-336, an oral small molecule LDHA …
8-K: CHINOOK THERAPEUTICS, INC. - MarketWatch
WebApr 13, 2024 · Chinook’s lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and proteinuric glomerular diseases. BION-1301, an anti-APRIL monoclonal ... WebApr 5, 2024 · Chinook’s lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. BION-1301, an anti-APRIL monoclonal antibody is being evaluated in a phase 1/2 trial for IgA nephropathy. In addition, Chinook is advancing CHK-336, an oral small molecule … green bay packers football radio
Checking Out Chinook Therapeutics Stock (NASDAQ:KDNY)
WebMar 21, 2024 · 27 Feb 2024 Chinook Therapeutics announces intention to submit NDA to US FDA for IgA nephropathy under accelerated approval pathway. 27 Feb 2024 Chinook Therapeutics attends a type B end of phase II meeting with US FDA to discuss the phase III ALIGN trial of atrasentan in IgA nephropathy prior to February 2024. Subscriber content. WebApr 11, 2024 · Chinook's lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and proteinuric glomerular diseases. … Web1 day ago · Chinook's lead program is atrasentan, a phase 3 endothelin receptor antagonist for the treatment of IgA nephropathy and proteinuric glomerular diseases. BION-1301, an anti-APRIL monoclonal ... green bay packers football playoff